Skip to main content

Haemophilus influenzae type b (Hib) Vaccines

  • Chapter
  • First Online:
Pediatric Vaccines and Vaccinations

Abstract

Haemophilus influenzae is a human-restricted pathogen that colonises the nose and throat and to a lesser extent the conjunctivae and genital tract.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Anderson EC, Begg NT, Crawshaw SC, Hargreaves RM, Howard AJ, Slack MP. Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2). Epidemiol Infect. 1995;115(1):89–100.

    Google Scholar 

  • Collins S, Ramsay M, Campbell H, Slack MP, Ladhani SN. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? Clin Infect Dis. 2013;57(12):1715–21.

    Article  PubMed  Google Scholar 

  • Daum RS, Zenko CE, Given GZ, et al. Magnitude of interference after diphtheria-tetanus toxoid-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide vaccination is related to the number of doses administered. J Infect Dis. 2001;184:1293–9.

    Article  CAS  PubMed  Google Scholar 

  • Dagan R, Poolman JT, Zepp F. Combination vaccines containing DTPaHib: impact of IPV and co-administration of CRM197 conjugates. Expert Rev Vaccines. 2008;7:97–115.

    Google Scholar 

  • Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 1992;120(2 pt. 1):184–9.

    Google Scholar 

  • European Centre for Disease Prevention and Control. Annual epidemiological report: invasive Haemophilus influenzae. Stockholm ECDC. 2016. Available at: http://ecdc.europa.eu/en/healthtopics/Haemophilus_Influenzae_Infection/Pages/Annual-epidemiological-report-2016.aspx

  • Käyhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147:1100.

    Article  PubMed  Google Scholar 

  • Käyhty H, Eskola J, Peltola H, et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Arch Dis Child. 1991;145(2):223–7.

    Google Scholar 

  • Kelly DF, Moxon ER, Pollard AJ. Haemophilus influenzae type b conjugate vaccines. Immunology. 2004;113:163–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ladhani S, Ramsay ME, Chandra M, Slack MP. EU-IBIS No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis. 2008;8(5):275–6.

    Article  PubMed  Google Scholar 

  • Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME. Invasive Haemophilus influenzae disease, Europe, 1996–2006. European Union invasive bacterial infection surveillance participants. Emerg Infect Dis. 2010a;16(3):455–63.

    Google Scholar 

  • Ladhani S, Heath PT, Slack MP, McIntyre PB, Diez-Domingo J, Campos J, Dagan R, Ramsay ME, Participants of the European Union Invasive Bacterial Infections Surveillance Network. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clin Microbiol Infect. 2010b;16(7):948–54.

    Article  CAS  PubMed  Google Scholar 

  • Ladhani SN, Ladhani SN, Collins S, Vickers A, Litt DJ, Crawford C, Ramsay ME, Slack MPE. Invasive Haemophilus influenzae serotype e and f disease in England and Wales. Emerg Infect Dis. 2012;18(5):725–32.

    Article  PubMed  PubMed Central  Google Scholar 

  • McVernon J, Howard AJ, Slack MP, Ramsay ME. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect. 2004;132:765–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pace D. Glycoconjugate vaccines. Expert Opin Biol Ther. 2013;13(1):11–33.

    Article  CAS  PubMed  Google Scholar 

  • Paul Erhlich Institute. Vaccines for Haemophilus influenzae type b. n.d.. Available at: http://www.pei.de/EN/medicinal-products/vaccines-human/haemophilus-influenzae-type-b-hib/haemophilus-influenzae-type-b-hib-node.html

  • Peltola H, Käyhty H, Sivonen A, Mäkelä H. Haemophilus influenzae type b capsular polysaccharide vaccine in children : a double blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977;60:730–7.

    Google Scholar 

  • Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Poolman J, Kaufhold A, DeGrave D, Goldblatt D. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine. 2001;19:2280–5.

    Article  CAS  PubMed  Google Scholar 

  • Slack MPE, Azzopardi HJ, Hargreaves RM, Ramsay ME. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccine. Pediatr Infect Dis J. 1998;17:S204–7.

    Article  CAS  PubMed  Google Scholar 

  • Sturgess AW, Rush K, Charbonneau RJ, et al. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerisation of PRP in the presence of aluminium hydroxide. Vaccine. 1999;17:1169–78.

    Article  CAS  PubMed  Google Scholar 

  • Takala A, Eskola J, Peltola H, Makela H. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Ped Infect Dis J. 1989;8:297–301.

    CAS  Google Scholar 

  • Takala AK, Meuman O, Kleemola M, et al. Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. Ped Infect Dis J. 1993;12:189–95.

    Article  CAS  Google Scholar 

  • Van Eldere J, Slack M, Ladhani S, Cripps A. Non-typeable Haemophilus influenzae: an under-recognised pathogen. Lancet Infect Dis. 2014;14(12):1281–92.

    Article  PubMed  Google Scholar 

  • Vidor E, Offenbach A, Fletcher MA. Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis- containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. Cur Med Res Open. 2001;17:197–209.

    Article  CAS  Google Scholar 

  • Watt JP, Wolfson LJ, O’Brien KL. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374:903–11.

    Article  PubMed  Google Scholar 

  • World Health Organisation. Third dose of Hib vaccine Reported estimates 2016. Available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragehib3.html

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary P. E. Slack MA MB BChir FRCPath .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Slack, M.P.E. (2017). Haemophilus influenzae type b (Hib) Vaccines. In: Vesikari, T., Van Damme, P. (eds) Pediatric Vaccines and Vaccinations. Springer, Cham. https://doi.org/10.1007/978-3-319-59952-6_19

Download citation

Publish with us

Policies and ethics